These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28087359)

  • 1. The effect of NMDA-R antagonism on simultaneously acquired local field potentials and tissue oxygen levels in the brains of freely-moving rats.
    Kealy J; Commins S; Lowry JP
    Neuropharmacology; 2017 Apr; 116():343-350. PubMed ID: 28087359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms.
    Hiyoshi T; Kambe D; Karasawa J; Chaki S
    Neuropharmacology; 2014 Oct; 85():384-96. PubMed ID: 24907590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
    Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
    Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission.
    Dimpfel W; Spüler M
    Psychopharmacology (Berl); 1990; 101(3):317-23. PubMed ID: 2163537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
    Pinault D
    Biol Psychiatry; 2008 Apr; 63(8):730-5. PubMed ID: 18022604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA receptor antagonist-enhanced high frequency oscillations: are they generated broadly or regionally specific?
    Olszewski M; Dolowa W; Matulewicz P; Kasicki S; Hunt MJ
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1795-805. PubMed ID: 23466347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor antagonists and antipsychotics on high frequency oscillations recorded in the nucleus accumbens of freely moving mice.
    Hunt MJ; Olszewski M; Piasecka J; Whittington MA; Kasicki S
    Psychopharmacology (Berl); 2015 Dec; 232(24):4525-35. PubMed ID: 26446869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D; Zhang J; Engel JA; Svensson L
    Behav Brain Res; 2005 Apr; 159(1):95-103. PubMed ID: 15795002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats.
    Ma J; Leung LS
    Psychopharmacology (Berl); 2007 May; 191(4):961-74. PubMed ID: 17219218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local NMDA receptor hypofunction evokes generalized effects on gamma and high-frequency oscillations and behavior.
    Lee J; Hudson MR; O'Brien TJ; Nithianantharajah J; Jones NC
    Neuroscience; 2017 Sep; 358():124-136. PubMed ID: 28676240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.
    Lindén A; Storvik M; Lakso M; Haapasalo A; Lee D; Witkin JM; Sei Y; Castrén E; Wong G
    Neuropharmacology; 2001 Mar; 40(4):469-81. PubMed ID: 11249956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain NMDA Receptors in Schizophrenia and Depression.
    Adell A
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory and inhibitory neurotransmission is chronically altered following perinatal NMDA receptor blockade.
    du Bois TM; Deng C; Han M; Newell KA; Huang XF
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):256-65. PubMed ID: 19150227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA-glutamatergic activation of the ventral tegmental area induces hippocampal theta rhythm in anesthetized rats.
    Matulewicz P; Orzeł-Gryglewska J; Kuśmierczak M; Jurkowlaniec E
    Brain Res Bull; 2014 Aug; 107():43-53. PubMed ID: 24915630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The olfactory bulb is a source of high-frequency oscillations (130-180 Hz) associated with a subanesthetic dose of ketamine in rodents.
    Hunt MJ; Adams NE; Średniawa W; Wójcik DK; Simon A; Kasicki S; Whittington MA
    Neuropsychopharmacology; 2019 Jan; 44(2):435-442. PubMed ID: 30140046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats.
    Sagratella S; Pezzola A; Popoli P; Scotti de Carolis AS
    Psychopharmacology (Berl); 1992; 109(3):277-82. PubMed ID: 1365627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.
    Jones NC; Reddy M; Anderson P; Salzberg MR; O'Brien TJ; Pinault D
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):657-68. PubMed ID: 21733235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness.
    Hakami T; Jones NC; Tolmacheva EA; Gaudias J; Chaumont J; Salzberg M; O'Brien TJ; Pinault D
    PLoS One; 2009 Aug; 4(8):e6755. PubMed ID: 19707548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.